(16676029), A. C. F., (16676032), D. K. M., (15084264), S. P. A., (16676035), A. E. S., (16676038), W. B., (16676041), L. J., . . . (16676080), S. D. R. (2025). Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.
Lua i Stíl Chicago (17ú heag.)(16676029), Alyssa C. Flint, et al. Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma. 2025.
Lua MLA (9ú heag.)(16676029), Alyssa C. Flint, et al. Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma. 2025.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.